NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction |
|
|
| Terminated | 3 | 535 | Europe, Canada, Japan, US, RoW | BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo | Remedy Pharmaceuticals, Inc. | Brain Edema, Stroke, Acute | 08/23 | 08/23 | | |
CANNASTROKE, NCT03379857: Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke |
|
|
| Active, not recruiting | N/A | 300 | Europe | Drug urinal test, Magnetic Resonance Imaging, Computerized Tomography Scan, Transcranial Doppler Ultrasound | University Hospital, Strasbourg, France | Stroke, Cannabis Use | 01/25 | 01/25 | | |
ACTRIS, NCT02841098: " Endarterectomy Combined With Optimal Medical Therapy (OMT) vs OMT Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke " |
|
|
| Completed | N/A | 43 | Europe | Carotid endarterectomy (CEA) combined with optimal medical therapy (OMT), Optimal medical therapy alone | Centre Hospitalier St Anne, Hôpitaux Universitaires Paris Ile-de-Franc Ouest | Asymptomatic Carotid Artery Stenosis | 01/22 | 01/22 | | |
